Analyze Diet
Immunobiology1998; 198(4); 424-438; doi: 10.1016/s0171-2985(98)80050-8

CD8 dimer usage on alpha beta and gama delta T lymphocytes from equine lymphoid tissues.

Abstract: Eight murine monoclonal antibodies (mAb) were used to identify the equine CD8 alpha or CD8 beta chains and to define the expression of these chains on lymphocytes from various lymphoid tissues. CD8 alpha was a 39 kDa protein and CD8 beta was a 32 kDa protein. Both chains were expressed on most of the CD8+ T lymphocytes in the peripheral blood, spleen, thymus, mesenteric lymph nodes and ileal intraepithelial lymphocytes (IEL), however, in each lymphoid compartment a percentage of lymphocytes expressed only the CD8 alpha chain. The largest percentage of CD8 alpha alpha expressing T lymphocytes was 37.7% of the IELs. Purified T lymphocytes from the ileum expressing CD8 alpha beta co-expressed the alpha beta T cell receptor (TCR). In contrast, purified CD8+ T lymphocytes from the PBMC co-expressed either the alpha beta or gamma delta TCR by RT-PCR. Use of pooled anti-CD8 alpha mAb of the murine IgG2a isotype and rabbit complement resulted in lysis of the entire CD8 expressing population in peripheral blood mononuclear cells (PBMC). These results indicated that CD8 dimer usage by equine T lymphocytes is similar to other species and that the mAb described can be further used to separate equine CD8+ T lymphocyte subsets from the lymphoid tissues to define their function in protection against viral and other infections.
Publication Date: 1998-05-01 PubMed ID: 9562867DOI: 10.1016/s0171-2985(98)80050-8Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research involves studying the expression of the CD8 alpha or CD8 beta chains on lymphocytes from certain parts of the equine lymph system, using eight types of murine monoclonal antibodies. Results indicate that CD8 dimer usage by equine T lymphocytes is similar to other species. This finding can be leverage to further segregation of equine CD8+ T lymphocyte subsets from the lymphoid tissues to understand their role in protection against infections.

The Use of Monoclonal Antibodies

  • Eight murine monoclonal antibodies (mAb) were used in this research. These antibodies can identify the equine CD8 alpha or CD8 beta chains expressed on lymphocytes in different areas of the lymph system.
  • The use of these antibodies allowed researchers to determine the understanding of dimer usage in T lymphocytes, paving the way for potential advancements in combating viral and other infections.

CD8 Alpha and Beta Chains and Their Expression on Lymphocytes

  • The CD8 alpha was identified as a 39 kDa protein and CD8 beta as a 32 kDa protein. Both chains were found on most of the CD8+ T lymphocytes present in the peripheral blood, spleen, thymus, mesenteric lymph nodes and even ileal intraepithelial lymphocytes (IEL).
  • However, in every lymphoid compartment studied, there was still a certain percentage of lymphocytes that had only the CD8 alpha chain expression.

Differences in CD8 Expression and Co-Expression in T Lymphocytes

  • The highest percentage of CD8 alpha alpha expressing T lymphocytes (up to 37.7%) was found in IELs.
  • It was also found that purified T lymphocytes derived from the ileum co-expressed both CD8 alpha beta and the alpha beta T cell receptor (TCR). However, purified CD8+ T lymphocytes from the peripheral blood mononuclear cells (PBMC) had the ability to co-express either the alpha beta or gamma delta TCR, as per RT-PCR results.

Lysis of CD8 Expressing Population

  • Utilizing the pooled anti-CD8 alpha mAb of the murine IgG2a isotype plus rabbit complement led to the lysis of the entire CD8 expressing population in the PBMC, which shows the power of these antibodies in potentially targeting specific lymphocyte populations.

Implication of the Findings

  • Overall, the findings of this research indicate that CD8 dimer usage by equine T lymphocytes is similar to others species.
  • This suggests that these monoclonal antibodies can be utilized further to differentiate distinct equine CD8+ T lymphocyte subsets from lymphoid tissues, and precisely define their function in potentially protecting against viral and other infections. This finding offers potential advancements in understanding and treating both equine and other infections in a number of species.

Cite This Article

APA
Tschetter JR, Davis WC, Perryman LE, McGuire TC. (1998). CD8 dimer usage on alpha beta and gama delta T lymphocytes from equine lymphoid tissues. Immunobiology, 198(4), 424-438. https://doi.org/10.1016/s0171-2985(98)80050-8

Publication

ISSN: 0171-2985
NlmUniqueID: 8002742
Country: Netherlands
Language: English
Volume: 198
Issue: 4
Pages: 424-438

Researcher Affiliations

Tschetter, J R
  • Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, USA.
Davis, W C
    Perryman, L E
      McGuire, T C

        MeSH Terms

        • Animals
        • Antibodies, Monoclonal
        • CD8 Antigens / immunology
        • CD8 Antigens / isolation & purification
        • Dimerization
        • Female
        • Horses
        • Lymphoid Tissue / immunology
        • Lymphoid Tissue / metabolism
        • Mice
        • Mice, Inbred BALB C
        • Rabbits
        • Receptors, Antigen, T-Cell, alpha-beta / chemistry
        • Receptors, Antigen, T-Cell, alpha-beta / immunology
        • Receptors, Antigen, T-Cell, gamma-delta / chemistry
        • Receptors, Antigen, T-Cell, gamma-delta / immunology
        • T-Lymphocyte Subsets / immunology
        • T-Lymphocyte Subsets / metabolism

        Grant Funding

        • 5 T32 GM08336 / NIGMS NIH HHS
        • AI24291 / NIAID NIH HHS

        Citations

        This article has been cited 3 times.
        1. Mealey RH, Littke MH, Leib SR, Davis WC, McGuire TC. Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: lack of correlation between in vitro activity and in vivo efficacy. Vet Immunol Immunopathol 2008 Jan 15;121(1-2):8-22.
          doi: 10.1016/j.vetimm.2007.07.011pubmed: 17727961google scholar: lookup
        2. Mealey RH, Littke MH, Leib SR, Davis WC, McGuire TC. Cloning and large-scale expansion of epitope-specific equine cytotoxic T lymphocytes using an anti-equine CD3 monoclonal antibody and human recombinant IL-2. Vet Immunol Immunopathol 2007 Jul 15;118(1-2):121-8.
          doi: 10.1016/j.vetimm.2007.04.001pubmed: 17498813google scholar: lookup
        3. Mealey RH, Fraser DG, Oaks JL, Cantor GH, McGuire TC. Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses. Clin Immunol 2001 Nov;101(2):237-47.
          doi: 10.1006/clim.2001.5109pubmed: 11683583google scholar: lookup